Pangea Biomed

Pangea Biomed is a biotech company that is redefining precision oncology by developing advanced computational technologies to predict patient response to cancer treatments. Their core product, the ENLIGHT platform, combines machine learning, artificial intelligence, and deep RNA analysis to map tumor molecular signatures and identify clinically relevant genetic interactions. This allows for the dynamic and adaptive personalization of cancer care, aiming to significantly increase the number of patients who can benefit from targeted and immunotherapies. Pangea also offers ENLIGHT-DP, a technology that uses deep learning to analyze digital H&E slide images and predict gene expression, providing actionable insights for treatment options without the need for genetic sequencing. The platform supports drug discovery, clinical trial design, and treatment nomination, targeting cancer patients, oncologists, and pharmaceutical companies.